PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 1989The Journal of Experimental Medicine289 citationsOpen Access

Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

TMTomohiko MatsuyamaAYAkira YamadaJKJonathan Kay

Key Points

Key points are not available for this paper at this time.

Abstract

In this study, fibronectin synergized with anti-CD3 antibody to promote CD4 cell proliferation in a serum-free culture system. The cell-adhesive domain plus additional regions of the fibronectin molecule are involved in this synergy. Anti4B4(CDw29) antibody blocked the activation of CD4 cells in this system. Furthermore, it is the VLA-5 protein within the set of molecules recognized by anti-4B4 that serves as a fibronectin receptor on the CD4 lymphocytes. The VLA-5 fibronectin receptor was mainly expressed on CD4+ CD45R-CDw29+ cells and may in part contribute to the unique function of these cells.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Matsuyama et al. (1989) studied this question.

synapsesocial.com/papers/6a1028964fb650da4fff06a2https://doi.org/10.1084/jem.170.4.1133
Ask AI
Helpful
Bookmark
Share
View Full Paper